{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T19:06:49Z","timestamp":1767467209545,"version":"3.48.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04541-6","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:25:36Z","timestamp":1764120336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lambert\u2013Eaton myasthenic syndrome presenting with occult mediastinal small cell carcinoma and positivity for anti-CV2\/CRMP5 and anti-SOX1 antibodies: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Anna","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dewen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"2","key":"4541_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ncl.2018.01.008","volume":"36","author":"VG Kesner","year":"2018","unstructured":"Kesner VG, Oh SJ, Dimachkie MM, et al. Lambert-Eaton Myasthenic Syndrome. Neurol Clin. 2018;36(2):379\u201394.","journal-title":"Neurol Clin"},{"key":"4541_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1196\/annals.1254.065","volume":"998","author":"DB Sanders","year":"2003","unstructured":"Sanders DB. Lambert-eaton myasthenic syndrome: diagnosis and treatment. Ann N Y Acad Sci. 2003;998:500\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"4541_CR3","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.clinph.2014.06.031","volume":"125","author":"R H\u00fclsbrink","year":"2014","unstructured":"H\u00fclsbrink R, Hashemolhosseini S. Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy. Clin Neurophysiol. 2014;125(12):2328\u201336.","journal-title":"Clin Neurophysiol"},{"key":"4541_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1749-6632.2012.06772.x","volume":"1275","author":"AF Lipka","year":"2012","unstructured":"Lipka AF, Verschuuren JJ, Titulaer MJ. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma. Ann N Y Acad Sci. 2012;1275:70\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"4541_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/1759-7714.13290","volume":"11","author":"C Li","year":"2020","unstructured":"Li C, Wang X, Sun L, et al. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: a case report. Thorac Cancer. 2020;11(2):465\u20139.","journal-title":"Thorac Cancer"},{"issue":"2","key":"4541_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49(2):146\u201354.","journal-title":"Ann Neurol"},{"key":"4541_CR7","doi-asserted-by":"crossref","unstructured":"Pascuzzi RM, Bodkin CL. Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: new developments in diagnosis and treatment. Neuropsychiatr Dis Treat. 2022;18:3001\u2013022.","DOI":"10.2147\/NDT.S296714"},{"key":"4541_CR8","doi-asserted-by":"publisher","unstructured":"Hean V, Camdessanch\u00e9 JP, Cath\u00e9bras P, Killian M. Paraneoplastic subacute sensory neuropathy with triple positive antineuronal antibodies associated with small-cell lung cancer. BMJ Case Rep. 2020;13(8):e235668. https:\/\/doi.org\/10.2147\/NDT.S296714","DOI":"10.2147\/NDT.S296714"},{"key":"4541_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235668","author":"V Hean","year":"2020","unstructured":"Hean V, Camdessanch\u00e9 JP, Cath\u00e9bras P, et al. Paraneoplastic subacute sensory neuropathy with triple positive antineuronal antibodies associated with small-cell lung cancer. BMJ Case Rep. 2020. https:\/\/doi.org\/10.1136\/bcr-2020-235668.","journal-title":"BMJ Case Rep"},{"issue":"12","key":"4541_CR10","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","volume":"10","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Lang B, Verschuuren JJ. Lambert-eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10(12):1098\u2013107.","journal-title":"Lancet Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04541-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04541-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04541-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T19:05:29Z","timestamp":1767467129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04541-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4541"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04541-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirmed that patients provided written informed consent for the publication of the literature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}